Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Other Accumulated Expenses (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Other Accumulated Expenses data on record, last reported at $2.9 million in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 124.57% year-over-year to $2.9 million; the TTM value through Oct 2025 reached $2.9 million, up 124.57%, while the annual FY2025 figure was $3.3 million, 216.84% up from the prior year.
  • Other Accumulated Expenses reached $2.9 million in Q4 2025 per KEQU's latest filing, down from $4.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $4.0 million in Q3 2025 and bottomed at $850000.0 in Q4 2023.
  • Average Other Accumulated Expenses over 5 years is $2.0 million, with a median of $1.5 million recorded in 2021.
  • Peak YoY movement for Other Accumulated Expenses: crashed 46.88% in 2023, then soared 216.84% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $1.3 million in 2021, then increased by 6.45% to $1.4 million in 2022, then plummeted by 40.14% to $850000.0 in 2023, then soared by 51.76% to $1.3 million in 2024, then soared by 124.57% to $2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $2.9 million in Q4 2025, $4.0 million in Q3 2025, and $3.3 million in Q2 2025.